Protara Therapeutics
TARA
TARA
60 hedge funds and large institutions have $157M invested in Protara Therapeutics in 2024 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
35.81% more ownership
Funds ownership: 50.64% → 86.45% (+36%)
72% less call options, than puts
Call options by funds: $345K | Put options by funds: $1.24M
Holders
60
Holding in Top 10
2
Calls
$345K
Puts
$1.24M
Top Buyers
| 1 | +$11.9M | |
| 2 | +$11.9M | |
| 3 | +$11M | |
| 4 |
Blackstone Inc
New York
|
+$8.87M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$7.92M |
Top Sellers
| 1 | -$3.22M | |
| 2 | -$1.03M | |
| 3 | -$906K | |
| 4 |
Two Sigma Advisers
New York
|
-$277K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$142K |